Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6500705rdf:typepubmed:Citationlld:pubmed
pubmed-article:6500705lifeskim:mentionsumls-concept:C0034493lld:lifeskim
pubmed-article:6500705lifeskim:mentionsumls-concept:C0027950lld:lifeskim
pubmed-article:6500705lifeskim:mentionsumls-concept:C1167622lld:lifeskim
pubmed-article:6500705lifeskim:mentionsumls-concept:C0023503lld:lifeskim
pubmed-article:6500705pubmed:issue3lld:pubmed
pubmed-article:6500705pubmed:dateCreated1984-12-31lld:pubmed
pubmed-article:6500705pubmed:abstractTextThe leukocytotoxic toxin pseudomonal leukocidin, produced by Pseudomonas aeruginosa, was radioiodinated with chloramine-T reagent. Binding of [125I]leukocidin to rabbit polymorphonuclear leukocytes was found to be concentration dependent at 37 degrees C. A Scatchard plot of binding data was linear, indicating that leukocidin binds to a single population of sites. The dissociation constant, KD, was calculated from the Scatchard plot to be 2.5 X 10(-7) M, and the number of binding sites per leukocyte was approximately 4.4 X 10(5). Unlabeled leukocidin or antileukocidin antibody reduced the binding of [125I]leukocidin to the leukocytes. A leukocidin-binding protein was extracted from rabbit polymorphonuclear leukocytes with Triton X-100 and purified by leukocidin-Sepharose 4B affinity column chromatography. Approximately 60 micrograms of binding protein was obtained from 8.1 mg of material extracted from the leukocytes. The binding protein had a molecular weight of about 50,000 as shown by sodium dodecyl sulfate-polyacrylamide slab gel electrophoresis and staining with silver nitrate. Under nondenaturing conditions, its molecular weight was also about 50,000, as shown by gel filtration-Sephadex G-200 chromatography. The 50,000-dalton protein purified in this way from rabbit polymorphonuclear leukocytes competitively inhibited the binding of leukocidin to leukocytes and inactivated leukocidin activity. With equimolar amounts of the 50,000-dalton protein and leukocidin, up to 90% inactivation of leukocidin was observed.lld:pubmed
pubmed-article:6500705pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6500705pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6500705pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6500705pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6500705pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6500705pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6500705pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6500705pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6500705pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6500705pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6500705pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6500705pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6500705pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6500705pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6500705pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6500705pubmed:languageenglld:pubmed
pubmed-article:6500705pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6500705pubmed:citationSubsetIMlld:pubmed
pubmed-article:6500705pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6500705pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6500705pubmed:statusMEDLINElld:pubmed
pubmed-article:6500705pubmed:monthDeclld:pubmed
pubmed-article:6500705pubmed:issn0019-9567lld:pubmed
pubmed-article:6500705pubmed:authorpubmed-author:HirayamaTTlld:pubmed
pubmed-article:6500705pubmed:authorpubmed-author:KatzDDlld:pubmed
pubmed-article:6500705pubmed:authorpubmed-author:NodaMMlld:pubmed
pubmed-article:6500705pubmed:authorpubmed-author:MatsudaFFlld:pubmed
pubmed-article:6500705pubmed:authorpubmed-author:NagamoriMMlld:pubmed
pubmed-article:6500705pubmed:issnTypePrintlld:pubmed
pubmed-article:6500705pubmed:volume46lld:pubmed
pubmed-article:6500705pubmed:ownerNLMlld:pubmed
pubmed-article:6500705pubmed:authorsCompleteYlld:pubmed
pubmed-article:6500705pubmed:pagination631-4lld:pubmed
pubmed-article:6500705pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:6500705pubmed:meshHeadingpubmed-meshheading:6500705-...lld:pubmed
pubmed-article:6500705pubmed:meshHeadingpubmed-meshheading:6500705-...lld:pubmed
pubmed-article:6500705pubmed:meshHeadingpubmed-meshheading:6500705-...lld:pubmed
pubmed-article:6500705pubmed:meshHeadingpubmed-meshheading:6500705-...lld:pubmed
pubmed-article:6500705pubmed:meshHeadingpubmed-meshheading:6500705-...lld:pubmed
pubmed-article:6500705pubmed:meshHeadingpubmed-meshheading:6500705-...lld:pubmed
pubmed-article:6500705pubmed:meshHeadingpubmed-meshheading:6500705-...lld:pubmed
pubmed-article:6500705pubmed:year1984lld:pubmed
pubmed-article:6500705pubmed:articleTitleBinding of pseudomonal leukocidin to rabbit polymorphonuclear leukocytes.lld:pubmed
pubmed-article:6500705pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6500705pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6500705lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6500705lld:pubmed